Marc Ferrante, MD, PhD
UZ Leuven
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marc Ferrante, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:49 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04982172 · Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel DiseasesUniversitaire Ziekenhuizen KU Leuven · completed · Inflammatory Bowel Diseases · principal investigator
- Ph3NCT04089345 · Stelara fOr ChRonic AntibioTic rEfractory pouchitiSUniversitaire Ziekenhuizen KU Leuven · completed · Pouchitis · principal investigator
- N/ANCT03142113 · Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative ColitisUniversitaire Ziekenhuizen KU Leuven · completed · Ulcerative Colitis
- N/ANCT02914717 · The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative ColitisUniversitaire Ziekenhuizen KU Leuven · completed · Ulcerative Colitis
- Ph4NCT02910375 · Golimumab Dried Blood Spot AnalysisUniversitaire Ziekenhuizen KU Leuven · unknown · Ulcerative Colitis
- N/ANCT02634060 · Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction DestinyUniversitaire Ziekenhuizen KU Leuven · completed · Crohn Disease, Colitis, Ulcerative
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.